ResearcherNational Health Insurance Service Ilsan HospitalActive in the last 2 years
Byung Kyu Park
Matched on ORCID iD 0000-0002-6801-3831; OpenAlex author ID A5048607899. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2022: 1 paper · 2023: 3 papers · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 7
- Effects of Chemotherapy on Survival Outcomes in Older Patients with Metastatic Pancreatic Cancer: A Nationwide Population-Based Study. First author DOI 10.5009/gnl250551↗
- Correction: Park et al. Real-World Outcomes of First-Line Chemotherapy in Metastatic Pancreatic Cancer: A Nationwide Population-Based Study in Korea. Cancers 2… First author DOI 10.3390/cancers17060963↗
- Real-World Outcomes of First-Line Chemotherapy in Metastatic Pancreatic Cancer: A Nationwide Population-Based Study in Korea. First author DOI 10.3390/cancers16183173↗
- Trends in treatment patterns and survival outcomes in pancreatic cancer: A nationwide population-based study in Korea. Co-author DOI 10.1016/j.ejca.2023.05.020↗
- Risk of pancreatic cancer after acute pancreatitis: A population-based matched cohort study. Co-author DOI 10.1016/j.pan.2023.05.001↗
- Suspicious findings observed retrospectively on CT imaging performed before the diagnosis of pancreatic cancer. Co-author DOI 10.21037/jgo-22-863↗
- Lifestyle, body mass index, diabetes, and the risk of pancreatic cancer in a nationwide population-based cohort study with 7.4 million Korean subjects. Co-author DOI 10.1038/s41416-022-01807-5↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kang Ju Son · 5 shared papers, 2023–2026 · strength 1.48
- Paper Effects of Chemotherapy on Survival Outcomes in Older Patients with Metastatic Pancreatic Cancer: A Nationwide Populati… DOI 10.5009/gnl250551↗
- Paper Correction: Park et al. Real-World Outcomes of First-Line Chemotherapy in Metastatic Pancreatic Cancer: A Nationwide Po… DOI 10.3390/cancers17060963↗
- Paper Real-World Outcomes of First-Line Chemotherapy in Metastatic Pancreatic Cancer: A Nationwide Population-Based Study in … DOI 10.3390/cancers16183173↗
- Kyong Joo Lee · 4 shared papers, 2023–2026 · strength 1.21
- Paper Effects of Chemotherapy on Survival Outcomes in Older Patients with Metastatic Pancreatic Cancer: A Nationwide Populati… DOI 10.5009/gnl250551↗
- Paper Correction: Park et al. Real-World Outcomes of First-Line Chemotherapy in Metastatic Pancreatic Cancer: A Nationwide Po… DOI 10.3390/cancers17060963↗
- Paper Real-World Outcomes of First-Line Chemotherapy in Metastatic Pancreatic Cancer: A Nationwide Population-Based Study in … DOI 10.3390/cancers16183173↗
- Chan Su Park · 3 shared papers, 2024–2026 · strength 1.00
- Paper Effects of Chemotherapy on Survival Outcomes in Older Patients with Metastatic Pancreatic Cancer: A Nationwide Populati… DOI 10.5009/gnl250551↗
- Paper Correction: Park et al. Real-World Outcomes of First-Line Chemotherapy in Metastatic Pancreatic Cancer: A Nationwide Po… DOI 10.3390/cancers17060963↗
- Paper Real-World Outcomes of First-Line Chemotherapy in Metastatic Pancreatic Cancer: A Nationwide Population-Based Study in … DOI 10.3390/cancers16183173↗
- Jung Kyu Choi · 3 shared papers, 2022–2023 · strength 0.71
- Paper Risk of pancreatic cancer after acute pancreatitis: A population-based matched cohort study. DOI 10.1016/j.pan.2023.05.001↗
- Paper Lifestyle, body mass index, diabetes, and the risk of pancreatic cancer in a nationwide population-based cohort study w… DOI 10.1038/s41416-022-01807-5↗
- Paper Trends in treatment patterns and survival outcomes in pancreatic cancer: A nationwide population-based study in Korea. DOI 10.1016/j.ejca.2023.05.020↗
- Jae Bock Chung · 1 shared paper, 2022 · strength 0.22
- Sumi Park · 1 shared paper, 2023 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.